Abstract:Abstract Background Researchers are increasingly focusing on the influence of micronutrient levels on the initiation and prognosis of Inflammatory Bowel Disease (IBD). Earlier investigations have highlighted a connection between deficiencies in zinc and selenium and an elevated risk of IBD development and unfavorable outcomes. This study seeks to investigate the existing micronutrient status among Chinese patients with IBD and assess whether deficiencies in trace elements are associated with disease activity, extent of intestinal involvement, and the use of biological treatments. Methods This cross-sectional study included patients diagnosed with Crohn's disease (CD) or ulcerative colitis (UC) who underwent plasma micronutrient testing during outpatient or inpatient visits to the Department of Gastroenterology at Peking Union Medical College Hospital from May 2022 to October 2023. Baseline data, the history of biological agent use, and laboratory inflammation parameters such as hsCRP, ESR, and Alb were extracted from the Electronic Medical Record System. Colonoscopy images were examined to assess the extent of intestinal involvement and endoscopic activity. The distribution of micronutrient deficiency among patients with varying disease statuses was explored using the Pearson chi-square test and Mann-Whitney U-test. Results Among the 168 participants with IBD in this study (77 with CD, 91 with UC), a frequent occurrence of deficiencies in copper, selenium, strontium, and zinc was noted. In CD patients in the endoscopic active phase, there was a higher incidence of selenium and zinc deficiencies compared to the remission phase (selenium 0% vs. 11.3%, p=0.17; zinc 4.2% vs. 24.5%, p=0.052). In UC patients during the endoscopic active phase, strontium (14.5% vs. 0%, p=0.053) and zinc (17.7% vs. 3.4%, p=0.094) deficiencies were more likely to occur. CD patients with zinc deficiency and UC patients lacking zinc or selenium showed higher levels of blood hsCRP and ESR but lower levels of serum albumin. UC patients with E3 type involvement were more prone to selenium and strontium deficiencies compared to those with only left colon involvement (selenium 18.5% vs. 2.7%, p=0.025; strontium 14.8% vs. 5.0%, p=0.078). Conclusion This study identified a notable prevalence of micronutrient deficiencies in individuals with IBD, particularly during active phases. Specifically, patients with CD in an inflammatory state are inclined to exhibit zinc deficiency. In the case of UC, the absence of selenium, strontium, and zinc signals a higher level of inflammation. UC patients with involvement of the entire colon are more prone to experiencing deficiencies in selenium and strontium. These findings warrant validation through multi-center study and mechanism invetigation.

Vitamins and Minerals in Inflammatory Bowel Disease

Adjunctive therapeutic effects of micronutrient supplementation in inflammatory bowel disease

Prevalence and Relevant Factors of Micronutrient Deficiencies in Hospitalized Patients with Inflammatory Bowel Disease.

Micronutrient deficiencies in inflammatory bowel disease: an incidence analysis

Nutritional aspects of inflammatory bowel disease

The Use of Antioxidants in Inflammatory Bowel Disease

Vitamin–Microbiota Crosstalk in Intestinal Inflammation and Carcinogenesis

Vitamin D Modulates Intestinal Microbiota in Inflammatory Bowel Diseases

The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management

Interplay of Immunity and Vitamin D: Interactions and Implications with Current IBD Therapy

Associations Between Folate And Vitamin B12 Levels And Inflammatory Bowel Disease: A Meta-Analysis

P428 Nutritional, Muscular status and micronutrient deficiencies in patients with Inflammatory Bowel Disease

Vitamin D improves inflammatory bowel disease outcomes: Basic science and clinical review

Zinc and Inflammatory Bowel Disease: From Clinical Study to Animal Experiment

Vitamin D, the gut microbiome and inflammatory bowel disease

P937 A Retropective Analysis of Micronutrient Status in Inflammatory Bowel Disease

Current Nutritional Therapies in Inflammatory Bowel Disease: Improving Clinical Remission Rates and Sustainability of Long-Term Dietary Therapies

Status of Serum Vitamin B12 and Folate in Patients with Inflammatory Bowel Disease in China.

Inflammatory bowel diseases: interrelationships between dietary vitamin D, exposure to UV radiation and the fecal microbiome

Micronutrient Deficiency and Muscular Status in Inflammatory Bowel Disease

The Potential Role of Vitamin E and the Mechanism in the Prevention and Treatment of Inflammatory Bowel Disease